tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech Shifts Corporate Domicile to British Columbia
Company AnnouncementsOncolytics Biotech Shifts Corporate Domicile to British Columbia
3d ago
8K
ONCY
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
PremiumCompany Announcements
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
4d ago
ONCY
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
PremiumCompany Announcements
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
4d ago
8K
ONCY
Oncolytics to present new data on Pelareorep at AACR 2026
PremiumThe Fly
Oncolytics to present new data on Pelareorep at AACR 2026
4d ago
ONCY
Oncolytics Biotech Advances Pelareorep Into New Phase 2 Colorectal Cancer Study
PremiumCompany Announcements
Oncolytics Biotech Advances Pelareorep Into New Phase 2 Colorectal Cancer Study
19d ago
ONCY
Is ONCY a Buy, Before Earnings?
PremiumPre-EarningsIs ONCY a Buy, Before Earnings?
20d ago
ONCY
Oncolytics Biotech Launches Phase 2 Colorectal Cancer Trial
Premium
Company Announcements
Oncolytics Biotech Launches Phase 2 Colorectal Cancer Trial
21d ago
8K
ONCY
Oncolytics initiates randomized colorectal cancer study
Premium
The Fly
Oncolytics initiates randomized colorectal cancer study
21d ago
ONCY
Oncolytics Refocuses Pipeline on Key GI Cancer Programs
PremiumCompany Announcements
Oncolytics Refocuses Pipeline on Key GI Cancer Programs
27d ago
8K
ONCY
Oncolytics concludes enrollment in GOBLET study
PremiumThe Fly
Oncolytics concludes enrollment in GOBLET study
27d ago
ONCY
Oncolytics Biotech receives FDA Fast Track for pelareorep
PremiumCompany Announcements
Oncolytics Biotech receives FDA Fast Track for pelareorep
2M ago
8K
ONCY
Pelareorep Platform Breakthrough Drives $10 Target and Buy Rating on Oncolytics Biotech
PremiumRatings
Pelareorep Platform Breakthrough Drives $10 Target and Buy Rating on Oncolytics Biotech
2M ago
ONCY
Oncolytics receives FDA Fast Track Designation for pelareorep
PremiumThe FlyOncolytics receives FDA Fast Track Designation for pelareorep
2M ago
ONCY
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
Premium
Weekend Updates
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
2M ago
AEO
ABEO
Oncolytics Biotech Shareholders Approve Redomiciliation to Nevada and New Incentive Plan
Premium
Company Announcements
Oncolytics Biotech Shareholders Approve Redomiciliation to Nevada and New Incentive Plan
2M ago
ONCY
Oncolytics Biotech Bolsters Late-Stage Cancer Push With New Strategy and Biostatistics Leaders
PremiumCompany Announcements
Oncolytics Biotech Bolsters Late-Stage Cancer Push With New Strategy and Biostatistics Leaders
2M ago
ONCY
Oncolytics appoints John McAdory as EVP, strategy and operations
PremiumThe Fly
Oncolytics appoints John McAdory as EVP, strategy and operations
2M ago
CGON
ONCY
Advancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
PremiumRatings
Advancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
2M ago
ONCY
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
PremiumCompany Announcements
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
2M ago
ONCY
Oncolytics announces updates data from GOBLET cohort 4
PremiumThe FlyOncolytics announces updates data from GOBLET cohort 4
2M ago
ONCY
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
Premium
Company Announcements
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
2M ago
ONCY
Oncolytics outlines strategic rationale for proposal to change jurisdiction
Premium
The Fly
Oncolytics outlines strategic rationale for proposal to change jurisdiction
2M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >